Cabaletta Bio (CABA) Net Cash Flow (2018 - 2025)

Cabaletta Bio's Net Cash Flow history runs 8 years deep, the most recent figure standing at $22.8 million for Q4 2025.

• On a quarterly basis, Net Cash Flow rose 443.86% year-over-year to $22.8 million in Q4 2025; TTM through Dec 2025 was -$81.0 million, a 176.86% decrease from a year earlier, with the FY2025 full-year figure at -$81.0 million, down 176.86% from the prior year.
• Net Cash Flow climbed to $22.8 million in Q4 2025 per CABA's latest filing, from -$85.4 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $77.7 million in Q4 2023 and bottomed at -$85.4 million in Q3 2025.
• The 5-year median for Net Cash Flow is $2.8 million (2021), against an average of -$922300.0.
• Across the five-year window, Net Cash Flow soared 649.01% in 2021 and slumped 1409.37% in 2022, its largest moves.
• Year by year, Net Cash Flow stood at $4.0 million in 2021, then soared by 416.0% to $20.4 million in 2022, then surged by 280.24% to $77.7 million in 2023, then slumped by 108.52% to -$6.6 million in 2024, then surged by 443.86% to $22.8 million in 2025.
• Per Business Quant, the three latest CABA Net Cash Flow figures stand at $22.8 million (Q4 2025), -$85.4 million (Q3 2025), and $13.8 million (Q2 2025).